Heart failure & cardiomyopathiesCohort study

Cardiovascular-Kidney-Metabolic Disease Burden in Children and Adults Following Heart Transplantation

JACC Heart FailPublished

  • Retrospective cohort study
  • single-centre

Authors' conclusion

A significant proportion of HT recipients experience new-onset or worsening CKM dysfunction after HT. Furthermore, CKM comorbidities are associated with post-HT mortality.

Study context

Population
Adults and children who underwent heart transplantation (HT), January 2015 to June 2024
Participants
860 vs 84
Exposure
Adults vs Children
  • Adultsn = 860
  • Childrenn = 84
Outcome
Incidence and prevalence of CKM risk factors (T2DM, overweight/obesity, hypertension, CKD, dyslipidaemia) and their association with CAV and mortality

Main finding

As reported in the abstract

Incidence rates of CKM risk factors (cases per 100 person-years)
GroupT2DMOverweight or obesityDyslipidaemiaChronic kidney disease (CKD)
Adults28.677.3139.169.7
Children2.826.95.53.6

Observational data: associations, not effects.

Further findings

Cardiovascular-kidney-metabolic (CKM) comorbidities and cardiac allograft vasculopathy (CAV) / post-HT mortality

ComparisonHR (95% CI)
DM2 · post-HT mortality · time-varying Cox regression1.84 (1.04–3.25)

Cardiometabolic dysfunction in adults · within 12 months post-HT

Stage 1 or 2 hypertension
99%
HbA1c ≥6.5%, regardless of preexisting diabetes mellitus (DM2)
22.1%
Moderate to severe hypertriglyceridemia
37.5%
Worsened LDL-C control
31.1%

Worsening renal function (estimated glomerular filtration rate (eGFR) <45 mL/min/1.73 m²) in adults with pre-HT eGFR ≥45 · within 12 months post-HT

Worsening renal function
86.2%

eGFR after SGLT2 inhibitor initiation post-HT (adults, n = 242) · ensuing 12 months

Nonlinear improvement in eGFR

BMI after GLP1RA initiation (adults, n = 168)

Predominantly linear reduction in BMI

CKM comorbidities and CAV / post-HT mortality

No CKM comorbidity significantly associated with CAV

Original publication

Cardiovascular-Kidney-Metabolic Disease Burden in Children and Adults Following Heart Transplantation. JACC Heart Fail. Published 20 October 2025. doi:10.1016/j.jchf.2025.102710

Summarised from the published abstract; every number is checked against it